31 August 2020: Database Analysis
, , and are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
Yiping Zou 12CE* , Shiye Ruan 1CD* , Liang Jin 1C , Zhihong Chen 1BF , Hongwei Han 1DF , Yuanpeng Zhang 1F , Zhixiang Jian 1G , Ye Lin 1D , Ning Shi 1AE* , Haosheng Jin 1AG*DOI: 10.12659/MSM.925289
Med Sci Monit 2020; 26:e925289
Figure 6 (A) CDK1, CCNB1, and CCNB2 mutation rates were 6%, 9%, and 9%, respectively. (B, C) Genetic alterations in CDK1, CCNB1, and CCNB2 were associated with shorter overall survival (OS) and disease-free survival (DFS) of HCC patients.